GSK PLC's ticker is and the CUSIP is 37733W204. A total of 817 filers reported holding GSK PLC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $160,020,880 | -11.1% | 4,156,387 | -1.0% | 0.03% | -15.6% |
| Q1 2024 | $180,064,547 | -12.2% | 4,200,246 | -24.1% | 0.03% | -13.5% |
| Q4 2023 | $205,154,250 | -15.4% | 5,535,733 | -17.3% | 0.04% | -27.5% |
| Q3 2023 | $242,545,155 | -37.3% | 6,690,901 | -38.4% | 0.05% | -38.6% |
| Q2 2023 | $386,963,172 | -12.5% | 10,857,553 | -12.7% | 0.08% | -18.6% |
| Q1 2023 | $442,428,348 | +29.6% | 12,434,748 | +28.0% | 0.10% | +21.4% |
| Q4 2022 | $341,257,380 | +143739.3% | 9,711,365 | +20.5% | 0.08% | +40.0% |
| Q3 2022 | $237,249 | – | 8,061,479 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |